NCT04332679View on ClinicalTrials.gov

Non-resorbable Membranes Versus Titanium Meshes and Resorbable Membranes

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2013

Primary Completion Date

September 1, 2016

Study Completion Date

September 1, 2019

Conditions
Surgical Procedure, UnspecifiedSoft Tissue InfectionsBone DensityBone LossDental Implant
Interventions
DEVICE

Group A - control group

20 patients treated by means of a dense PTFE (d-PTFE) titanium-reinforced membrane (Cytoplast Ti-250XL; Osteogenics Biomedical) and simultaneous implants placement (BT SAFE; Biotec srl, Vicenza, Italy).

DEVICE

Group B - Test group

20 patients treated by means of Ti mesh (Trinon Titanium; Karlsruhe, Germany) and cross-linked collagen membrane (Osseoguard, Zimmer Biomet, Warsaw, IN, USA) and simultaneous implants placement (BT SAFE; Biotec srl, Vicenza, Italy).

Trial Locations (1)

40126

School of Dentistry - University of Bologna, Bologna

All Listed Sponsors
lead

GBR Academy

NETWORK

NCT04332679 - Non-resorbable Membranes Versus Titanium Meshes and Resorbable Membranes | Biotech Hunter | Biotech Hunter